Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.
Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Scientific Reports|April 14, 2026
Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trialMichael Neumann, Hardik Kothare, Meredith Bartlett, et al.
Neuroinformatics|May 18, 2021
The C-BIG Repository: an Institution-Level Open Science PlatformSamir Das, Rida Abou-Haidar, Henri Rabalais, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
The Lancet. Neurology|April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 studyJames F Howard, Saskia Bresch, Angela Genge, et al.
The New England Journal of Medicine|September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALSTimothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Annals of Clinical and Translational Neurology|January 11, 2022
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALSJonathan S Katz, Jeffrey D Rothstein, Merit E Cudkowicz, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating StudyStacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Pageof 13